← Back to Search

Health Coaching + Medication Reminders for High Blood Pressure (MAP Trial)

N/A
Recruiting
Led By Marie A Krousel-Wood, MD, MSPH
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fully insured by Blue Cross Blue Shield of Louisiana (BCBSLA)
Currently filling antihypertensive medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

MAP Trial Summary

This trial is testing a health coaching program to see if it helps people with hypertension better manage their blood pressure and take their medication as prescribed.

Who is the study for?
This trial is for people over 50 with high blood pressure who struggle to stick to their medication schedule. They must be insured by Blue Cross Blue Shield of Louisiana, plan to stay with them next year, speak English, have a phone, and not live with someone in the study or be in another drug adherence trial.Check my eligibility
What is being tested?
The STAR-MAP program's effectiveness is being tested against just using medication reminder tools. The program includes health coaching sessions aimed at improving how well participants take their blood pressure medicine and manage their condition.See study design
What are the potential side effects?
Since this trial focuses on health coaching and reminders rather than new medications, side effects are minimal but may include discomfort from discussing personal habits or frustration if no improvement in medication adherence is seen.

MAP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am fully insured by Blue Cross Blue Shield of Louisiana.
Select...
I am currently taking medication for high blood pressure.
Select...
I have been diagnosed with high blood pressure.
Select...
I am 50 years old or older.

MAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in proportion with PDC >=0.8 at 12 months
Secondary outcome measures
Difference in change in proportion with high adherence as measured by urine metabolite analysis, baseline to 12 months
Difference in mean change in 4-item Krousel-Wood Medication Adherence Scale score, baseline to 12 months
Difference in mean change in DBP, baseline to 12 months
+5 more
Other outcome measures
Difference in change in proportion with high adherence as measured by urine metabolite analysis, baseline to 24 months
Difference in change in proportion with high adherence as measured by urine metabolite analysis, baseline to 6 months
Difference in mean change in 4-item Krousel-Wood Medication Adherence Scale score, baseline to 24 months
+13 more

MAP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: STAR-MAPExperimental Treatment2 Interventions
Interactive health coaching sessions and medication reminder tools
Group II: Medication App and Reminder System Medication Adherence Program (MARS-MAP)Active Control1 Intervention
Medication reminder tools only

Find a Location

Who is running the clinical trial?

Tulane UniversityLead Sponsor
115 Previous Clinical Trials
226,100 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,225 Total Patients Enrolled
Ohio State UniversityOTHER
829 Previous Clinical Trials
505,233 Total Patients Enrolled

Media Library

STAR-MAP health coaching Clinical Trial Eligibility Overview. Trial Name: NCT05183763 — N/A
High Blood Pressure Research Study Groups: STAR-MAP, Medication App and Reminder System Medication Adherence Program (MARS-MAP)
High Blood Pressure Clinical Trial 2023: STAR-MAP health coaching Highlights & Side Effects. Trial Name: NCT05183763 — N/A
STAR-MAP health coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT05183763 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size of this research project?

"Affirmative. Clinicaltrials.gov details the current search for volunteers, which began on March 7th 2022 and was most recently updated in mid-July of that same year. A total 402 enrollees are sought from four distinct medical sites."

Answered by AI

How many health care facilities are conducting this experiment?

"At the present, 4 sites are actively enrolling participants in this research study. These locations include Baton Rouge, Metairie, and New Orleans etc., so it is advisable to select a trial site near you for convenience's sake."

Answered by AI

Is this investigation currently enrolling participants?

"Affirmative. Clinicaltrials.gov confirms that the enrollment for this study is ongoing, having been initiated on March 7th 2022 and updated as recently as July 15th 2022. 402 patients are being sought out from 4 distinct medical venues."

Answered by AI

Who else is applying?

What site did they apply to?
LSU Health Sciences Shreveport Clinical Trials Office
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Medication Adherence Program
2022. "Medication Adherence Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05183763.
~197 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top